Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Betaglucin 0.2% Gel Versus Imiquimod Cream 5% in the Treatment of Anogenital Warts in 102 Individuals Older Than 18 Years.

NCT03901690 is registered in ClinicalTrials.gov with Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri as lead sponsor.

NCT NCT03901690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03901690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Betaglucin 0.2% Gel Versus Imiquimod Cream 5% in the Treatment of Anogenital Warts in 102 Individuals Older Than 18 Years.
Lead sponsor
Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri
Phase
Phase 3
Overall status
Unknown status
Start date
August 27, 2019
Completion date
May 20, 2020
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital wart virus infection